Avery Dennison has announced a commitment to transition its pharmaceutical portfolio to recycled polyethylene terephthalate (rPET) liners by the end of next year.  

This strategic move is aimed at reducing the environmental impact of the company’s pharmaceutical packaging and supporting its customers in achieving their sustainability objectives. 

As part of the latest effort, the company will convert its PET30 and PET23 liners to rPET grades containing 30% post-consumer recycled (PCR) material.  

This initiative is further expected to help its customers reduce scope 3 emissions and improve their respective carbon footprints. 

Avery’s approach to this transition involves a 12-month validation period in line with its Pharma Change Management protocols.  

The company said its AD Circular programme further complements this move by offering a recycling service for used film and paper label liners in European countries. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Avery Dennison anticipates substantial annual savings from the change, including approximately 532,000kg of carbon dioxide and 2,266,000 litres of water, based on 2023 sales volumes, as well as calculations from the Carbon Trust tool.

According to Avery, the rPET liners are designed to meet the rigorous demands of the pharmaceutical industry and are suitable for applications such as syringes, eye drops, insulin pens, and security seals.  

Key features of the rPET liners include no impact on the conversion or label dispensing process, a PCR layer encapsulated between two layers of virgin material, and a silicone coating that retains quality and performance.  

The liners are certified under the Global Recycled Standard (GRS), highlighting Avery’s commitment to sustainable manufacturing practices. 

Recently, Avery Dennison Label and Packaging Materials announced the launch of new 30% PCR waste versions of three classic wine labels under its Wine and Spirits portfolio.